Patents by Inventor Bjorn G. Ingelman

Bjorn G. Ingelman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 4804537
    Abstract: The present invention relates to a process and means for separating motile sperm cells in vitro from an aqueous sperm-containing sample by means of contacting said sample with a layer of an aqueous artificial penetration medium for sperm cells, said medium having incorportated therein a water-soluble physiologically acceptable salf of hyaluronic acid, whereby motile sperm cells are caused to migrate into said layer from said sperm-containing sample. The invention also comprises fertilization with sperm cells separated in this manner.
    Type: Grant
    Filed: May 22, 1987
    Date of Patent: February 14, 1989
    Assignee: Pharmacia AB
    Inventors: Per O. Bergman, Yvonne M. Steen, Bjorn G. Ingelman
  • Patent number: 4201772
    Abstract: A sterile aqueous solution containing 0.
    Type: Grant
    Filed: March 28, 1978
    Date of Patent: May 6, 1980
    Assignee: Pharmacia Aktiebolag
    Inventors: Bjorn G. Ingelman, Ary W. Richter, Kirsti A. Granath
  • Patent number: 3980770
    Abstract: A pharmaceutical product containing amino groups, which product:A. is comprised of residues of one or more diamines of the general formulaH.sub.2 N.CH.sub.2. phenylene.CH.sub.2.NH.sub.2 (I)which residues are interconnected by bridges between the residues to form a three-dimensional network, the bridges being bound to nitrogen atoms in the residues (I) and comprise straight or branched aliphatic, saturated hydrocarbon chains substituted with one or more hydroxyl groups and containing 3-30 carbon atoms, preferably 3-16 carbon atoms and which are optionally broken by one or more oxygen atoms, the amino groups being present in a free form or in the form of (the cation portion of) a non-toxic salt, andB. is insoluble in water or other solvents, but capable of swelling in water to gel form, 1 g of the dry product in the form of an HCl salt in the presence of water swelling to at least 5 ml and to at most 50 ml, preferably to at least 5 ml and to at most 25 ml, andC.
    Type: Grant
    Filed: December 5, 1974
    Date of Patent: September 14, 1976
    Assignee: Pharmacia Aktiebolag
    Inventors: Bjorn G.-A. Ingelman, Bernt J. Lindberg, Jan G. Rosengren, Dag E. S. Campbell